Anti-melanoma TILs used in this study
| Cells | % CD8 | % CD4 | % Transf. |
| TIL219 | 21 | 79 | 98 |
| TIL52 | 69.6 | 30.4 | 99 |
| TIL14 | 99.1 | 0.85 | 98 |
| TIL213 | 51.5 | 48.5 | 98 |
| TIL86 | 70.2 | 29.8 | 98 |
Shown are the TILs CD8/CD4 composition and mRNA transfection efficiency. All TILs are HLA-A2+ and are responsive to HLA-A2+ melanomas.
TILs, tumor-infiltrating lymphocytes.